Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?

Crit Rev Oncol Hematol. 2023 Aug:188:104044. doi: 10.1016/j.critrevonc.2023.104044. Epub 2023 Jun 1.

Abstract

Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are epithelial neoplasms in which neuroendocrine and non-neuroendocrine discrete components are combined, each of which constitutes ≥ 30% of the neoplasm. The finding of an additional neuroendocrine component seems to characterize the tumor's biological behavior. Few studies have proved MiNENs histogenetic and molecular characterization, and the development of molecular markers for more accurate classification of MiNENs represents a clinical need. However, a common origin of the neuroendocrine and non-neuroendocrine components from a pluripotent cancer stem cell could be suggested. The optimal clinical management of MiNENS is largely unknown. Whenever feasible, curative-intent resection should be performed for localized disease; in advanced disease, the treatment should be targeted to the component responsible for the metastatic spreading. This paper provides a revision of the current knowledge on MiNENs, focusing on available evidence about their molecular characterization to suggest a prognostic stratification of these rare forms.

Keywords: Classification; MANEC; MiNENs; Mixed neuroendocrine-non-neuroendocrine neoplasms; Molecular characterization; Neuroendocrine neoplasms.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Carcinoma*
  • Humans
  • Neuroendocrine Tumors* / diagnosis
  • Neuroendocrine Tumors* / genetics
  • Neuroendocrine Tumors* / therapy
  • Prognosis

Substances

  • Biomarkers, Tumor